Clinical Trials

Tocilizumab vs Azathioprine in Neuromyelitis Optica Spectrum Disorders

Conditions:   Neuromyelitis Optica Spectrum Disorders;   Neuromyelitis Optica
Interventions:   Drug: Tocilizumab Injection;   Drug: Azathioprine
Sponsor:   Tianjin Medical University General Hospital
Completed
Wed, 22 Nov 2017 12:00:00 EST

The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD

Condition:   Crohn Disease
Interventions:   Drug: infliximab and azathioprine combination at week 0;   Drug: infliximab and azathioprine combination at week 14
Sponsor:   Sixth Affiliated Hospital, Sun Yat-sen University
Unknown status
Mon, 08 Jan 2018 12:00:00 EST

Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients

Condition:   Neuromyelitis Optica Spectrum Disorder
Interventions:   Drug: Azathioprine;   Drug: Rituximab
Sponsor:   Isfahan University of Medical Sciences
Completed
Fri, 23 Dec 2016 12:00:00 EST

Alitretinoin vs Azathioprine in Severe Non-hyperkeratotic Hand Eczema

Condition:   Hand Eczema
Interventions:   Drug: Alitretinoin;   Drug: Azathioprine
Sponsor:   University Medical Center Groningen
Unknown status
Fri, 20 Jan 2017 12:00:00 EST

Cimzia Versus Cimzia Plus Azathioprine in the Treatment of Active Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Biological: Certolizumab pegol;   Drug: Azathioprine
Sponsors:   Gastroenterology Research of America;   UCB Pharma
Unknown status
Tue, 26 Mar 2013 12:00:00 EDT

Imuran Dosing in Crohn's Disease Study

Condition:   Crohn's Disease
Interventions:   Drug: Azathioprine weight-based dose;   Drug: Azathioprine individualised dose
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   Prometheus Laboratories
Terminated
Thu, 09 Jun 2005 12:00:00 EDT

Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis

Conditions:   Colitis, Ulcerative;   Colitis Ulcerative Exacerbation
Interventions:   Drug: Azathioprine and Allopurinol;   Drug: Azathioprine
Sponsors:   Hvidovre University Hospital;   Aalborg University Hospital;   Zealand University Hospital;   University of Copenhagen;   Odense University Hospital;   Aarhus University Hospital;   Regional Hospital Viborg;   Vejle Hospital;   Sydvestjysk Hospital Esbjerg
Unknown status
Wed, 05 Apr 2017 12:00:00 EDT

Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients

Condition:   Inflammatory Bowel Disease
Intervention:   Drug: Azathioprine / Allopurinol
Sponsor:   University of Zurich
Completed
Mon, 23 Feb 2009 12:00:00 EST

LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis

Condition:   Autoimmune Hepatitis
Interventions:   Drug: LCP-Tacro (tacrolimus);   Drug: Azathioprine
Sponsor:   Veloxis Pharmaceuticals
Terminated
Wed, 06 Feb 2008 12:00:00 EST

Drug Use Investigation for IMURAN (Azathioprine) Tablet (Hepatic Transplantation)

Condition:   Liver Diseases
Intervention:   Drug: Azathioprine
Sponsor:   GlaxoSmithKline
Completed
Mon, 11 Jul 2011 12:00:00 EDT

Special Drug Use Investigation for IMURAN (Azathioprine) Tablet (Pulmones Transplantation)

Condition:   Liver Diseases
Intervention:   Drug: Azathioprine
Sponsor:   GlaxoSmithKline
Completed
Mon, 27 Jun 2011 12:00:00 EDT

Addition of Azathioprine in IBD Patients With Immunogenic Failure

Condition:   Clinical Failure After Switch
Interventions:   Drug: addition of azathioprine;   Drug: Switch to a second anti-TNF drug alone
Sponsor:   Védrines, Philippe, M.D.
Unknown status
Mon, 09 Jul 2018 12:00:00 EDT

Azathioprine in Recurrent Implantation Failure

Conditions:   Recurrent Implantation Failure;   In Vitro Fertilization;   Intracytoplsmic Sperm Injection
Interventions:   Drug: Azathioprine Pill;   Drug: Placebo Oral Tablet
Sponsors:   Ain Shams University;   Capital Birth Center
Completed
Tue, 17 Apr 2018 12:00:00 EDT

Effect of the Exclusive Enteral Nutrition Combined With Azathioprine for Remission of Crohn's Diseases After Surgery

Condition:   Crohn Disease
Interventions:   Dietary Supplement: postoperative 3-month exclusive enteral nutrition;   Drug: azathioprine;   Other: normal diet
Sponsors:   Zhu Weiming;   Sixth Affiliated Hospital, Sun Yat-sen University;   Sir Run Run Shaw Hospital;   The First Affiliated Hospital of Anhui Medical University;   Beijing Tsinghua Changgeng Hospital
Recruiting
Wed, 13 Nov 2019 12:00:00 EST

Rituximab Vasculitis Maintenance Study

Conditions:   Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   Microscopic Polyangiitis;   Wegener Granulomatosis
Interventions:   Biological: Rituximab;   Drug: Azathioprine
Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   Arthritis Research UK;   Roche Pharma AG;   Genentech, Inc.;   University of Pennsylvania
Completed
Tue, 02 Oct 2012 12:00:00 EDT

Myfortic Versus Azathioprine in Systemic Lupus Erythematosus

Condition:   Systemic Lupus Erythematosus
Interventions:   Drug: switch to Myfortic;   Drug: continuation of azathioprine
Sponsors:   Erasmus Medical Center;   Novartis Pharmaceuticals
Terminated
Thu, 19 Jul 2007 12:00:00 EDT

Imuran (Azathioprine) Dose-Ranging Study in Crohn's Disease

Condition:   Crohn's Disease
Intervention:   Drug: azathioprine
Sponsor:   Massachusetts General Hospital
Terminated
Mon, 06 Dec 2004 12:00:00 EST

Azathioprine Versus Placebo in Pemphigus Vulgaris Treated With Prednisolone

Condition:   Pemphigus Vulgaris
Interventions:   Drug: Azathioprine;   Drug: Prednisone;   Drug: Placebo
Sponsor:   Tehran University of Medical Sciences
Completed
Fri, 29 Feb 2008 12:00:00 EST

Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis

Conditions:   Nephritis;   Lupus
Interventions:   Drug: Leflunomide;   Drug: Azathioprine
Sponsors:   RenJi Hospital;   Changhai Hospital;   Shanghai 10th People's Hospital;   Shanghai Zhongshan Hospital;   The First Affiliated Hospital with Nanjing Medical University;   The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School;   The First Affiliated Hospital of Soochow University;   Zhejiang University;   Second Affiliated Hospital, School of Medicine, Zhejiang University;   First Affiliated Hospital of Wenzhou Medical University;   Qilu Hospital of Shandong University;   AnHui ShengLi Hospital;   First Affiliated Hospital Bengbu Medical College;   The First Affiliated Hospital of Anhui Medical University
Unknown status
Thu, 29 Jul 2010 12:00:00 EDT

Steroids and Azathioprine in Advanced IgAN

Conditions:   IgA Nephropathy;   Chronic Kidney Disease
Interventions:   Drug: methylprednisolone;   Drug: azathioprine;   Drug: prednisone
Sponsor:   A. Manzoni Hospital
Completed
Wed, 13 Jul 2011 12:00:00 EDT

Comparison of Sirolimus and Azathioprine in Lung Transplantation

Conditions:   Delayed Graft Function;   Acute Graft Rejection
Interventions:   Drug: azathioprine;   Drug: sirolimus
Sponsors:   University of Chicago;   Astellas Pharma Inc;   Loyola University;   University of Florida;   University of Pennsylvania;   Baylor College of Medicine;   Ochsner Health System;   Columbia University;   University of Wisconsin, Madison
Completed
Thu, 04 May 2006 12:00:00 EDT

Comparison Azathioprine to Mesalazine for the Prevention of Postoperative Recurrence in the Crohn Disease

Condition:   Crohn Disease
Intervention:   Drug: Azathioprine OR Mesalazine
Sponsor:   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Completed
Mon, 14 Sep 2009 12:00:00 EDT

Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®)

Condition:   Therapeutic Equivalency
Interventions:   Drug: Azathioprine 50Mg Tab;   Drug: Azathioprine 10mg/mL oral suspension
Sponsors:   Nova Laboratories Limited;   Medicines Evaluation Unit Ltd;   Syne Qua Non Limited;   Alderley Analytical Ltd;   Black County Pathology Services;   Diamond Pharma Services Regulatory Affairs Consultancy;   Boyd Consultants
Completed
Mon, 29 Apr 2019 12:00:00 EDT

To Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory Urticaria

Condition:   Chronic Refractory Urticaria
Intervention:   Drug: cyclosporine vs azathioprine
Sponsor:   Postgraduate Institute of Medical Education and Research
Completed
Tue, 15 Aug 2017 12:00:00 EDT

Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.

Conditions:   Crohn Disease;   Recurrence;   Azathioprine;   Prevention
Interventions:   Drug: Azathioprine;   Drug: Azathioprine in case of endoscopic recurrence;   Procedure: Ileocolonoscopy;   Procedure: Small bowel follow trough
Sponsors:   Universitaire Ziekenhuizen Leuven;   International organization for the study of inflammatory bowel disease (IOIBD)
Terminated
Tue, 23 Sep 2014 12:00:00 EDT

Mycophenolate Mofetil Versus Azathioprine in Treatment Naive Autoimmune Hepatitis

Condition:   Autoimmune Hepatitis
Interventions:   Drug: Mycophenolate mofetil;   Drug: Azathioprine
Sponsors:   Radboud University;   Leiden University Medical Center
Unknown status
Wed, 14 Sep 2016 12:00:00 EDT

Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine

Condition:   Crohn's Disease
Interventions:   Drug: Azathioprine;   Drug: Mesalazine;   Drug: Azathioprine placebo;   Drug: Mesalazine placebo
Sponsor:   Dr. Falk Pharma GmbH
Completed
Mon, 27 Jul 2009 12:00:00 EDT

Correlation of Genetic Polymorphism of Azathioprine Metabolizing Enzymes and Correlation to Clinical Adverse Effects

Conditions:   Azathioprine;   Thiopurine Methyltransferase;   Inosine Triphosphate Pyrophosphatase;   Genetic Polymorphism
Intervention:   Drug: Azathioprine
Sponsor:   National Taiwan University Hospital
Completed
Wed, 05 Sep 2007 12:00:00 EDT

Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated Vasculitis

Conditions:   ANCA Associated Vasculitis;   Maintenance Therapy
Interventions:   Drug: Leflunomide;   Drug: Azathioprine Tablets
Sponsors:   Chinese SLE Treatment And Research Group;   Shanghai Zhongshan Hospital;   Affiliated Hospital of Jilin University, Changchun,China;   Second Affiliated Hospital of Nanchang University;   The First Affiliated Hospital of Anhui Medical University;   Beijing Shijitan Hospital, Capital Medical University;   The Affiliated Hospital of Inner Mongolia Medical University;   The First Affiliated Hospital of Kunming Medical College;   Sichuan Province People's Hospital;   Second Affiliated Hospital, School of Medicine, Zhejiang University
Not yet recruiting
Wed, 03 Feb 2021 12:00:00 EST

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Drug: Mycophenolate mofetil;   Drug: Azathioprine;   Drug: Prednisolone
Sponsor:   Genovate Biotechnology Co., Ltd.,
Completed
Mon, 31 Oct 2016 12:00:00 EDT

"Steroids and Azathioprine Versus Steroids Alone in IgAN"

Condition:   IGA Nephropathy
Interventions:   Drug: steroids plus azathioprine;   Drug: steroids
Sponsor:   A. Manzoni Hospital
Completed
Fri, 19 Sep 2008 12:00:00 EDT

Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.

Condition:   Lupus Nephritis
Interventions:   Drug: Mycophenolate mofetil;   Drug: Azathioprine
Sponsor:   Frédéric A. Houssiau, MD, PhD
Completed
Tue, 20 Sep 2005 12:00:00 EDT

Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.

Condition:   Eosinophilic Granulomatosis With Polyangiitis
Interventions:   Drug: Rituximab;   Drug: Azathioprine;   Drug: Placebo-rituximab;   Drug: Placebo-azathioprine
Sponsors:   Assistance Publique - Hôpitaux de Paris;   French Vasculitis Study Group
Recruiting
Tue, 23 May 2017 12:00:00 EDT

A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis

Condition:   Ulcerative Colitis
Interventions:   Drug: Azathioprine;   Drug: Infliximab;   Drug: Prednisolone;   Drug: Hydrocortisone
Sponsor:   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Recruiting
Fri, 24 Apr 2015 12:00:00 EDT

Azathioprine Based on Endoscopy After Clinical Remission in Moderate to Severe Ulcerative Colitis

Condition:   Ulcerative Colitis
Interventions:   Drug: Azathioprine;   Drug: Placebo
Sponsors:   Kyungpook National University Hospital;   Celltrion
Terminated
Tue, 20 Oct 2015 12:00:00 EDT

Post-Operative Crohn's Disease Outcome in Children

Condition:   Crohn Disease
Interventions:   Drug: Azathioprine;   Drug: Anti-TNF Drug
Sponsor:   Schneider Children's Medical Center, Israel
Recruiting
Mon, 24 Sep 2018 12:00:00 EDT

The Efficacy and Safety of Leflunomide or Azathioprine Therapy in Myasthenia Gravis Patients After Expand Thymectomy

Condition:   Myasthenia Gravis
Interventions:   Drug: Azathioprine;   Drug: Leflunomide
Sponsor:   First Affiliated Hospital, Sun Yat-Sen University
Unknown status
Thu, 15 Nov 2012 12:00:00 EST

Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis

Condition:   Vasculitis
Intervention:   Drug: azathioprine
Sponsors:   University Medical Center Groningen;   ZonMw: The Netherlands Organisation for Health Research and Development;   Dutch Arthritis Association;   Dutch Kidney Foundation
Terminated
Wed, 10 Aug 2005 12:00:00 EDT

Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease

Conditions:   Antisynthetase Syndrome (ASS);   Interstitial Lung Disease
Interventions:   Drug: Cyclophosphamide and azathioprine;   Drug: Tacrolimus
Sponsor:   Assistance Publique - Hôpitaux de Paris
Recruiting
Mon, 10 Dec 2018 12:00:00 EST

Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus Manifestations

Condition:   Systemic Lupus Erythematosus
Interventions:   Drug: Azathioprine;   Drug: Enteric-Coated Mycophenolate Sodium
Sponsor:   Hospital Universitari Vall d'Hebron Research Institute
Completed
Wed, 28 Apr 2010 12:00:00 EDT

A Randomised Clinical Trial Assessing the Efficacy and Safety of Mycophenolate Mofetil Versus Azathioprine for Induction of Remission in Treatment Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome

Conditions:   Autoimmune Hepatitis;   Primary Biliary Cirrhosis
Interventions:   Drug: Methylprednisolone and Mycophenolate mofetil;   Drug: Methylprednisolone and azathioprine
Sponsor:   Xiaoli Fan
Recruiting
Mon, 21 Jun 2021 12:00:00 EDT

Disease-Modifying Treatments for Myasthenia Gravis

Conditions:   Neurological Disorder;   Autoimmune Diseases
Interventions:   Drug: Mycophenolate Mofetil;   Drug: Azathioprine
Sponsors:   Duke University;   Beth Israel Deaconess Medical Center;   Patient-Centered Outcomes Research Institute
Completed
Fri, 06 Apr 2018 12:00:00 EDT

Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease in Patients With Common Variable Immunodeficiency

Condition:   Granulomatous and Lymphocytic Interstitial Lung Disease
Interventions:   Drug: Rituximab (RTX) and Azathioprine (AZA);   Drug: Placebos
Sponsor:   Medical College of Wisconsin
Withdrawn
Fri, 03 Jun 2016 12:00:00 EDT

Azathioprine Versus Corticosteroids in Parthenium Dermatitis

Condition:   Parthenium Dermatitis
Intervention:   Drug: azathioprine and corticosteroids for Parthenium dermatitis
Sponsor:   All India Institute of Medical Sciences, New Delhi
Completed
Mon, 19 Sep 2005 12:00:00 EDT

Belimumab in Remission of VASculitis

Condition:   Vasculitis
Interventions:   Biological: Placebo;   Biological: Belimumab 10 mg/kg;   Drug: Azathioprine
Sponsors:   Human Genome Sciences Inc., a GSK Company;   GlaxoSmithKline
Completed
Mon, 13 Aug 2012 12:00:00 EDT

Tolerization Reduces Intolerance to Pegloticase and Prolongs the Urate Lowering Effect

Condition:   Gout
Interventions:   Biological: Pegloticase;   Drug: Azathioprine
Sponsors:   Ampel BioSolutions, LLC;   IND 2 Results LLC
Active, not recruiting
Fri, 06 Nov 2015 12:00:00 EST

The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)

Condition:   Crohn's Disease
Interventions:   Drug: azathioprine+enteral nutrition;   Drug: Azathioprine
Sponsor:   Jinling Hospital, China
Unknown status
Thu, 04 Apr 2013 12:00:00 EDT

Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)

Conditions:   MPA;   PAN or EGPA With FFS=0;   At Diagnosis or Within the First 15 Days Following Initiation of Corticosteroids
Interventions:   Drug: corticosteroid and azathioprine;   Drug: corticosteroid and placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed
Mon, 31 Mar 2008 12:00:00 EDT

Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONIC

Condition:   Crohn Disease
Interventions:   Biological: infliximab infusion; AZA placebo caps;   Other: infliximab (IFX) infusion; azathioprine (AZA) caps;   Drug: infliximab (IFX) placebo infusion; azathioprine (AZA) caps
Sponsors:   Centocor Ortho Biotech Services, L.L.C.;   Schering-Plough
Completed
Wed, 20 Oct 2004 12:00:00 EDT

Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator

Conditions:   Inflammatory Bowel Disease;   Ulcerative Colitis;   Crohn's Disease
Interventions:   Drug: Azathioprine;   Drug: 6 mercaptopurine;   Drug: Methotrexate
Sponsor:   Indiana University
Terminated
Thu, 09 Apr 2015 12:00:00 EDT

Study Comparing Two Tapering Strategies of Prednisone in Myasthenia Gravis

Condition:   Myasthenia Gravis
Intervention:   Drug: Prednisone - Azathioprine
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed
Wed, 30 Sep 2009 12:00:00 EDT

Reposition of Second Line Treatment in Chronic Immune Thrombocytopenia

Condition:   Immune Thrombocytopenia
Interventions:   Drug: Hydroxychloroquine;   Drug: vincristine;   Drug: azathioprine
Sponsor:   Assiut University
Completed
Wed, 26 Jul 2017 12:00:00 EDT

Early Immunosuppressants in Crohn's Disease

Condition:   Crohn's Disease
Intervention:   Drug: early immunosuppressants (azathioprine, methotrexate)
Sponsors:   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives;   Société Nationale Française de Gastroentérologie
Completed
Fri, 19 Oct 2007 12:00:00 EDT

Reduce Risk for Crohn's Disease Patients

Condition:   Crohn's Disease
Interventions:   Drug: Methotrexate;   Drug: Adalimumab;   Drug: Azathioprine / 6 Mercaptopurine
Sponsors:   PIBD-Net;   European Commission
Recruiting
Tue, 02 Aug 2016 12:00:00 EDT

Thiopurine Induced Pancreatitis in IBD Patients

Conditions:   Pancreatitis;   Inflammatory Bowel Diseases
Intervention:   Drug: Azathioprine
Sponsors:   Shaare Zedek Medical Center;   Sydney Children's Hospitals Network;   Christchurch Hospital
Withdrawn
Tue, 04 Nov 2014 12:00:00 EST

Zileuton for the Treatment of Idiopathic Pulmonary Fibrosis

Condition:   Idiopathic Pulmonary Fibrosis
Interventions:   Drug: zileuton;   Drug: azathioprine/prednisone
Sponsors:   University of Michigan;   National Institutes of Health (NIH)
Completed
Tue, 06 Dec 2005 12:00:00 EST

Efficacy & Safety of Infliximab Monotherapy Vs Combination Therapy Vs AZA Monotherapy in Ulcerative Colitis (Part 1) Maintenance Vs Intermittent Therapy for Maintaining Remission (Part 2)(Study P04807)

Condition:   Ulcerative Colitis
Interventions:   Biological: Infliximab (IFX);   Drug: Azathioprine (AZA);   Drug: Placebo to Azathioprine;   Drug: Placebo infusion
Sponsor:   Merck Sharp & Dohme Corp.
Terminated
Mon, 01 Oct 2007 12:00:00 EDT

MMF vs. AZA for Kidney Transplantation

Condition:   Kidney Transplant
Interventions:   Drug: mycophenolate mofetil;   Drug: azathioprine
Sponsors:   Mario Negri Institute for Pharmacological Research;   Agenzia Italiana del Farmaco
Completed
Mon, 02 Jul 2007 12:00:00 EDT

Pre-genotype NUDT 15 R139C on Reducing Thiopurine-induced Leucopenia in Inflammatory Bowel Disease

Condition:   Thiopurine-induced Leukopenia
Intervention:   Genetic: Pre-genotype NUDT15 and optimize azathioprine dosage
Sponsors:   Sixth Affiliated Hospital, Sun Yat-sen University;   Sir Run Run Shaw Hospital
Unknown status
Tue, 11 Oct 2016 12:00:00 EDT

Cost-effectiveness of TPMT Pharmacogenetics

Conditions:   Inflammatory Bowel Diseases;   Crohn Disease;   Ulcerative Colitis
Interventions:   Genetic: TPMT genotyping; Drug: azathioprine or 6-mercaptopurine;   Drug: azathioprine (AZA) or 6-mercaptopurine (6-MP)
Sponsors:   ZonMw: The Netherlands Organisation for Health Research and Development;   Radboud University
Completed
Tue, 28 Aug 2007 12:00:00 EDT

Two Therapeutic Strategies for the Maintenance of Remission in Patients With Ulcerative Colitis

Condition:   Colitis, Ulcerative
Interventions:   Drug: Azathioprine;   Drug: Infliximab
Sponsors:   Istituto Clinico Humanitas;   Agenzia Italiana del Farmaco
Unknown status
Fri, 12 May 2017 12:00:00 EDT

Infliximab Top-down in Pediatric Crohn

Condition:   Crohn's Disease
Interventions:   Drug: Azathioprine;   Drug: Infliximab;   Drug: Prednisolon
Sponsors:   Erasmus Medical Center;   University of Roma La Sapienza;   Universitair Ziekenhuis Brussel
Terminated
Tue, 18 Jun 2013 12:00:00 EDT

Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease

Condition:   Crohn´s Disease
Interventions:   Drug: Metronidazole;   Drug: Azathioprine;   Drug: Adalimumab
Sponsors:   Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa;   Effice Servicios Para la Investigacion S.L.
Completed
Wed, 28 Mar 2012 12:00:00 EDT

A Randomized Multicenter Study for Isolated Skin Vasculitis

Conditions:   Primary Cutaneous Vasculitis;   Cutaneous Polyarteritis Nodosa;   IgA Vasculitis;   Henoch-Schönlein Purpura
Interventions:   Drug: Colchicine;   Drug: Dapsone;   Drug: Azathioprine
Sponsors:   University of Pennsylvania;   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS);   National Center for Advancing Translational Science (NCATS);   Office of Rare Diseases (ORD)
Recruiting
Thu, 20 Oct 2016 12:00:00 EDT

Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation

Conditions:   Kidney Failure, Chronic;   Kidney Transplantation;   Immunosuppression
Interventions:   Drug: Sirolimus;   Drug: MMF or Azathioprine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed
Wed, 08 Oct 2008 12:00:00 EDT

Efficacy Study of Two Treatments in the Remission of Vasculitis

Conditions:   Wegener Granulomatosis;   Microscopic Polyangiitis
Interventions:   Drug: Rituximab;   Drug: Azathioprine
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed
Mon, 08 Sep 2008 12:00:00 EDT

Efficacy Study of T2 Versus AZA to Maintain Clinical and Endoscopic Remission in Postoperative Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Drug: T2;   Drug: Azathioprine
Sponsor:   Jinling Hospital, China
Unknown status
Wed, 18 Nov 2009 12:00:00 EST

Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease

Condition:   Pediatric Crohn's Disease
Interventions:   Drug: Top-down;   Drug: Step-up
Sponsor:   University of Roma La Sapienza
Withdrawn
Wed, 19 Dec 2012 12:00:00 EST

Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant

Condition:   Cardiac Transplant
Interventions:   Drug: everolimus;   Drug: azathioprine or mycophenolate mofetil
Sponsor:   Fundacion Investigacion y Desarrollo
Unknown status
Wed, 11 Jun 2008 12:00:00 EDT

Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study

Condition:   Left Ventricular Hypertrophy
Intervention:   Drug: Everolimus
Sponsor:   Instituto de Urologia e Nefrologia
Unknown status
Thu, 09 Jul 2015 12:00:00 EDT

Efficacy and Safety of Two Regimens of Maintenance Therapy in Children With Crohn Disease

Condition:   Crohn Disease
Interventions:   Drug: Infliximab with azathioprine (IIFX + AZA);   Drug: Infliximab (IFX alone)
Sponsor:   Children's Memorial Health Institute, Poland
Unknown status
Wed, 21 Mar 2012 12:00:00 EDT

TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study

Condition:   Ocular Myasthenia Gravis
Intervention:   Drug: Symptomatic Treatment, Steroids, Immunosuppressive Agents( azathioprine, tacrolimus, Mycophenolate Mofetil)
Sponsor:   Tang-Du Hospital
Recruiting
Mon, 02 Dec 2019 12:00:00 EST

Comparison of Low Dose Versus High Dose Cyclophosphamide as Induction Therapy in the Treatment of Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
Sponsor:   Jawaharlal Institute of Postgraduate Medical Education & Research
Completed
Fri, 01 Jan 2016 12:00:00 EST

Comparison of 2 Immunomodulator Withdrawal Schemes for Infliximab Monotherapy in Active Pediatric Crohn's Disease After Thiopurine Failure

Condition:   Crohn's Disease
Intervention:   Drug: AZATHIOPRINE or METHOTREXATE
Sponsor:   Prof. Arie Levine
Terminated
Fri, 01 Mar 2013 12:00:00 EST

Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases

Condition:   Inflammatory Bowel Diseases
Interventions:   Drug: Infliximab;   Drug: Mercaptopurine;   Drug: Azathioprine
Sponsor:   University Hospital, Lille
Terminated
Tue, 12 Dec 2017 12:00:00 EST

Top-down Infliximab Study in Kids With Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Drug: Infliximab;   Drug: Prednisolone;   Other: Exclusive enteral nutrition;   Drug: Azathioprine
Sponsors:   Erasmus Medical Center;   ZonMw: The Netherlands Organisation for Health Research and Development;   Hospira, now a wholly owned subsidiary of Pfizer
Active, not recruiting
Fri, 07 Aug 2015 12:00:00 EDT

A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.

Condition:   Lupus Nephritis
Interventions:   Drug: Mycophenolate Mofetil;   Drug: Corticosteroids;   Drug: Azathioprine;   Drug: Cyclophosphamide
Sponsor:   Hoffmann-La Roche
Terminated
Tue, 23 Jan 2007 12:00:00 EST

Possible Role of Chloroquine to Induce a Complete Remission in the Treatment of Autoimmune Hepatitis: a Randomized Trial

Condition:   Autoimmune Hepatitis
Interventions:   Drug: Chloroquine diphosphate;   Drug: prednisone;   Drug: azathioprine
Sponsor:   University of Sao Paulo General Hospital
Completed
Thu, 04 Jun 2015 12:00:00 EDT

Effectiveness of Rifaximin Combined With Thiopurine on Preventing Postoperative Recurrence in Crohn's Disease

Condition:   Crohn Disease
Interventions:   Drug: Rifaximin;   Drug: Azathioprine
Sponsors:   Sixth Affiliated Hospital, Sun Yat-sen University;   First Affiliated Hospital, Sun Yat-Sen University;   Peking Union Medical College Hospital;   Xijing Hospital;   Shanghai 10th People's Hospital;   RenJi Hospital;   Sir Run Run Shaw Hospital
Unknown status
Wed, 14 Jun 2017 12:00:00 EDT

Study to Evaluate the Efficacy of Immunosuppression in Myocarditis or Inflammatory Cardiomyopathy.

Conditions:   Myocarditis;   Heart Failure;   Endomyocardial Biopsy;   Cardiomyopathies, Secondary;   Immunosuppression
Interventions:   Drug: Prednisone;   Drug: Azathioprine;   Drug: Placebo Prednisone;   Drug: Placebo Azathioprine
Sponsor:   Medical University of Warsaw
Not yet recruiting
Fri, 04 Dec 2020 12:00:00 EST

Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease

Conditions:   Crohn Disease;   Nutrient; Excess;   Remission/Regression
Interventions:   Dietary Supplement: EEN (Nestle Modulen®);   Drug: Standart of care
Sponsor:   Duzce University
Recruiting
Thu, 10 Jun 2021 12:00:00 EDT

Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Drug: Multi-target therapy;   Drug: Azathioprine
Sponsor:   Zhi-Hong Liu, M.D.
Completed
Tue, 26 Jan 2010 12:00:00 EST

Immune Tolerance Study With Aldurazyme® (Laronidase)

Condition:   Mucopolysaccharidosis I
Interventions:   Biological: Laronidase;   Drug: Cyclosporine A (CsA);   Drug: Azathioprine (Aza)
Sponsors:   Genzyme, a Sanofi Company;   BioMarin/Genzyme LLC
Completed
Tue, 26 Aug 2008 12:00:00 EDT

Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis

Condition:   Ulcerative Colitis
Interventions:   Drug: Prednisone;   Drug: Azathioprine;   Drug: Adalimumab;   Biological: umbilical cord blood mononuclear cells
Sponsor:   Shandong Qilu Stem Cells Engineering Co., Ltd.
Recruiting
Wed, 12 May 2021 12:00:00 EDT

Thalidomide Results in Diminished Ovarian Reserve in Reproductive Age Female IBD Patients

Condition:   Crohn Disease
Interventions:   Drug: Thalidomide;   Drug: infliximab, azathioprine;   Other: enteral nutrition
Sponsor:   Sixth Affiliated Hospital, Sun Yat-sen University
Unknown status
Tue, 20 Dec 2016 12:00:00 EST

A Study of Mycophenolate Mofetil (CellCept) in Management of Patients With Lupus Nephritis.

Condition:   Lupus Nephritis
Interventions:   Drug: Mycophenolate mofetil (MMF);   Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Placebo to Azathioprine;   Drug: Placebo to Mycophenolate mofetil;   Drug: Corticosteroid
Sponsors:   Hoffmann-La Roche;   Aspreva Pharmaceuticals
Completed
Mon, 18 Sep 2006 12:00:00 EDT

Immunoadsorption, Dexamethasone Pulse Therapy and Rituximab for Pemphigus

Condition:   Pemphigus
Intervention:   Drug: Combination of Protein A Immunoadsorption, Rituximab, Dexamethasone plus Azathioprine
Sponsor:   University of Luebeck
Completed
Fri, 11 Apr 2008 12:00:00 EDT

Five-Year Actively Controlled Clinical Trial in New Onset Juvenile Systemic Lupus Erythematosus Nephritis

Condition:   Systemic Lupus Erythematosus Nephritis
Intervention:   Drug: cyclophosphamide-prednisone-azathioprine
Sponsor:   Istituto Giannina Gaslini
Withdrawn
Tue, 13 Jun 2006 12:00:00 EDT

Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart Transplantation

Condition:   Heart Transplantation
Interventions:   Drug: Mycophenolatmofetile;   Drug: Cyclosporin A
Sponsors:   Hannover Medical School;   Hoffmann-La Roche
Completed
Wed, 02 Aug 2006 12:00:00 EDT

Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation

Condition:   Kidney Transplant Rejection
Interventions:   Drug: Antithymocyte Immunoglobulin (Rabbit);   Drug: Interleukin 2 Receptor Antagonist
Sponsors:   University of Khartoum;   National Center for Kidney Diseases and Surgery
Recruiting
Fri, 28 Dec 2018 12:00:00 EST

CZECH-ICIT (CZECH Inflammatory Cardiomyopathy Immunosuppression Trial)

Condition:   Inflammatory Cardiomyopathy
Interventions:   Drug: Combination of prednisone and azathioprine;   Other: No intervention
Sponsor:   St. Anne's University Hospital Brno, Czech Republic
Unknown status
Fri, 14 Jun 2013 12:00:00 EDT

Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Biological: Adalimumab;   Drug: Prednisone;   Drug: Azathioprine
Sponsor:   AbbVie (prior sponsor, Abbott)
Completed
Fri, 05 Nov 2010 12:00:00 EDT

Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

Condition:   Eosinophilic Granulomatosis With Polyangiitis
Interventions:   Drug: Mepolizumab;   Drug: cyclophosphamide/azathioprine;   Drug: Placebo
Sponsors:   Assistance Publique - Hôpitaux de Paris;   French Vasculitis Study Group;   URC-CIC Paris Descartes Necker Cochin
Not yet recruiting
Wed, 01 Sep 2021 12:00:00 EDT

A Phase 3 Clinical Trial of CCX168 (Avacopan) in Patients With ANCA-Associated Vasculitis

Condition:   ANCA-Associated Vasculitis
Interventions:   Drug: CCX168;   Drug: Prednisone;   Drug: Cyclophosphamide;   Biological: Rituximab;   Drug: Azathioprine
Sponsor:   ChemoCentryx
Completed
Fri, 16 Dec 2016 12:00:00 EST

Clinical Study Comparing the New Immunosuppressive Drug Gusperimus With the Conventional Treatment in Wegener's Granulomatosis

Condition:   Wegeners Granulomatosis
Interventions:   Drug: Gusperimus + glucocorticoids;   Drug: cyclophosphamide followed by methotrexate (azathioprine) + glucocorticoids or methotrexate (azathioprine) + glucocorticoids
Sponsor:   Nordic Pharma SAS
Terminated
Wed, 05 Oct 2011 12:00:00 EDT

Reduced Intensity Transplantation for Severe Sickle Cell Disease

Condition:   Sickle Cell Disease
Interventions:   Drug: hydroxyurea, azathioprine, alemtuzumab, thioptepa, low dose total body irradiation and sirolimus;   Drug: hydroxyurea, azathioprine, alemtuzumab, thiotepa, plerixafor, low dose total body irradiation, cyclophosphamide and sirolimus
Sponsor:   St. Jude Children's Research Hospital
Recruiting
Fri, 24 Apr 2020 12:00:00 EDT

Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

Condition:   Carcinoma, Hepatocellular
Interventions:   Drug: Everolimus;   Drug: Tacrolimus;   Drug: Myfortic;   Drug: CellCept;   Drug: Imuran
Sponsor:   Baylor Research Institute
Unknown status
Fri, 07 Mar 2014 12:00:00 EST

Therapeutic Optimization Study Based on MR Enterocolonography in Patients With Crohn's Disease

Condition:   Crohn Disease
Intervention:   Drug: azathioprine or adalimumab and infliximab
Sponsor:   Tokyo Medical and Dental University
Unknown status
Tue, 06 Jan 2015 12:00:00 EST

N-3 Polyunsaturated Fatty Acids Prevent Postoperative Recurrence of Crohn's Disease

Conditions:   Inflammatory Bowel Diseases;   Crohn Disease;   Polyunsaturated Acid Lipidosis
Interventions:   Drug: azathioprine;   Drug: infliximab;   Drug: N-3 Polyunsaturated Fatty Acids
Sponsor:   Sixth Affiliated Hospital, Sun Yat-sen University
Not yet recruiting
Sun, 21 Feb 2021 12:00:00 EST

Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial

Conditions:   Crohn Disease;   Azathioprine;   Methotrexate
Interventions:   Drug: AZA capsules;   Drug: MTX;   Biological: blood sample
Sponsor:   Centre Hospitalier Universitaire, Amiens
Recruiting
Fri, 10 Sep 2021 12:00:00 EDT

TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL )

Conditions:   Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions:   Drug: infliximab;   Drug: placebo
Sponsors:   Medical University of Vienna;   Hospital Hietzing;   Medical University of Graz;   Charite University, Berlin, Germany;   University of Erlangen-Nürnberg;   Heinrich-Heine University, Duesseldorf;   University Medical Center Groningen;   Leiden University Medical Center;   Radboud University
Terminated
Thu, 24 Aug 2006 12:00:00 EDT

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

Condition:   Pulmonary Fibrosis
Interventions:   Drug: N-acetylcysteine (NAC);   Drug: Placebo
Sponsors:   Duke University;   National Heart, Lung, and Blood Institute (NHLBI)
Completed
Tue, 01 Apr 2008 12:00:00 EDT

Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence

Condition:   Cytomegalovirus Infections
Interventions:   Drug: Drug conversion to sirolimus;   Drug: Maintenance of the current regimen
Sponsor:   Hospital do Rim e Hipertensão
Unknown status
Tue, 02 Feb 2016 12:00:00 EST

Clinical and Imaging Patterns of Neuroinflammation Diseases in China (CLUE)

Conditions:   NMO Spectrum Disorder;   MRI;   Multiple Sclerosis
Intervention:   Drug: Intravenous steroid
Sponsor:   Beijing Tiantan Hospital
Recruiting
Fri, 27 Sep 2019 12:00:00 EDT

Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens

Condition:   Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions:   Drug: Retinoic acid;   Drug: Standard of care
Sponsors:   University of North Carolina, Chapel Hill;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Withdrawn
Wed, 12 Jan 2011 12:00:00 EST

Turkish Acquired Haemophilia Registry

Condition:   Acquired Haemophilia
Intervention:   Drug: rFVIIIa, aPCC, FVIII, DDAVP, Azathioprine, Rituximab, Cyclosporin
Sponsor:   Turkish Society of Hematology
Unknown status
Wed, 27 Jul 2011 12:00:00 EDT

Effect of JKB-122 on Prednisolone and Azathioprine Induced Remission in Autoimmune Hepatitis (AIH)

Condition:   Autoimmune Hepatitis
Interventions:   Drug: JKB-122;   Other: Placebo
Sponsor:   TaiwanJ Pharmaceuticals Co., Ltd
Not yet recruiting
Fri, 01 May 2020 12:00:00 EDT

Assessment of Lesion Activity Analysis in the Avonex- Steroid Azathioprine (ASA) Study

Condition:   Multiple Sclerosis, Relapsing-remitting
Intervention:   Device: MRI
Sponsors:   University at Buffalo;   Charles University, Czech Republic;   General University Hospital, Prague
Completed
Tue, 26 Jun 2012 12:00:00 EDT

Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis

Condition:   Myasthenia Gravis
Interventions:   Drug: Mycophenolic acid;   Drug: AZA
Sponsor:   Qualitix Clinical Research Co., Ltd.
Unknown status
Mon, 19 Oct 2009 12:00:00 EDT

The Iguratimod Effect on Lupus Nephritis (IGeLU)

Condition:   Lupus Nephritis
Interventions:   Drug: Iguratimod;   Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Steroids
Sponsor:   RenJi Hospital
Recruiting
Tue, 18 Oct 2016 12:00:00 EDT

Cyclophosphamide and Hydroxychloroquine for Thrombocytopenia in SLE

Condition:   Thrombocytopenia
Interventions:   Drug: Hydroxychloroquine;   Drug: Cyclophosphamide;   Drug: Azathioprine;   Drug: Methylprednisolone
Sponsors:   Chinese SLE Treatment And Research Group;   Peking Union Medical College Hospital
Unknown status
Thu, 14 May 2015 12:00:00 EDT

Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

Condition:   Lung Transplant; Complications
Interventions:   Drug: Tacrolimus Extended Release Oral Tablet [Envarsus];   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil Hydrochloride;   Drug: Prednisone;   Drug: Azathioprine
Sponsors:   Vanderbilt University Medical Center;   Veloxis Pharmaceuticals
Not yet recruiting
Tue, 14 Jul 2020 12:00:00 EDT

Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

Conditions:   Kidney Diseases;   Lupus Nephritis;   Tacrolimus;   Induction Phase;   Maintenance Phase
Interventions:   Drug: tacrolimus (FK506);   Drug: cyclophosphamide or azathioprine
Sponsor:   Sun Yat-sen University
Completed
Thu, 14 Feb 2008 12:00:00 EST

Weaning of Immunosuppression in Nephritis of Lupus

Condition:   Nephritis of Lupus
Interventions:   Drug: mycophenolate mofetil or azathioprine;   Other: immunosuppressive treatment discontinuation
Sponsor:   Assistance Publique Hopitaux De Marseille
Active, not recruiting
Thu, 27 Jan 2011 12:00:00 EST

Abdominal Ultrasound With Doppler and Peripheral Hemogram in Assesment Inflammatory Bowel Disease

Condition:   Inflammatory Bowel Diseases
Intervention:   Drug: Infliximab
Sponsor:   Assiut University
Recruiting
Mon, 26 Feb 2018 12:00:00 EST

Use of Immunosuppressive Therapy for Sarcoidosis

Condition:   Sarcoidosis
Intervention:   Other: Cytotoxic drug
Sponsor:   University of Cincinnati
Unknown status
Thu, 05 Feb 2015 12:00:00 EST

Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study

Condition:   Adult-Onset Still's Disease
Interventions:   Drug: anakinra;   Drug: comparators
Sponsors:   University of Helsinki;   Uppsala University Hospital;   Helse Stavanger HF;   Tampere University Hospital;   Turku University Hospital;   Oulu University Hospital;   Kuopio University Hospital;   Jyväskylä Central Hospital;   Satakunta Central Hospital;   University Hospital, Umeå;   University Hospital, Linkoeping
Completed
Wed, 16 Dec 2009 12:00:00 EST

Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease

Conditions:   Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis;   End Stage Renal Disease
Interventions:   Other: Discontinuation (or not initiation) of Immunosuppressive Therapy;   Drug: Maintenance (or initiation) of immunosuppressive treatment: Imurel®, Mabthera®,Cellcept®, Cortancyl®
Sponsor:   Centre Hospitalier Departemental Vendee
Recruiting
Fri, 27 Oct 2017 12:00:00 EDT

Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

Condition:   Disorder Related to Cardiac Transplantation
Interventions:   Drug: Everolimus;   Drug: Mycophenolic acid (MPA)/azathioprine (AZA);   Drug: Calcineurin inhibitors (CNI);   Drug: Steroids
Sponsor:   Novartis Pharmaceuticals
Completed
Tue, 19 Sep 2006 12:00:00 EDT

Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732)

Condition:   Crohn's Disease
Interventions:   Biological: Infliximab;   Drug: AZA;   Drug: Placebo Prednisolone;   Drug: Prednisolone;   Biological: Placebo Infliximab
Sponsor:   Merck Sharp & Dohme Corp.
Terminated
Mon, 24 Nov 2008 12:00:00 EST

Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis

Conditions:   Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions:   Drug: abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN)
Completed
Fri, 17 Oct 2008 12:00:00 EDT

Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation

Condition:   Kidney Transplantation (Status Post)
Interventions:   Biological: GSK1070806;   Drug: 1) basiliximab 2) mycophenolate mofetil (MMF) OR azathioprine 3) tacrolimus 4) corticosteroids
Sponsor:   GlaxoSmithKline
Terminated
Wed, 30 Mar 2016 12:00:00 EDT

Liver Immunosuppression Free Trial

Condition:   Transplantation, Liver
Interventions:   Genetic: Biomarker;   Drug: Tacrolimus, cyclosporine and/or mycophenolic acid, mycophenolate mofetil or azathioprine
Sponsors:   King's College London;   King's College Hospital NHS Trust;   National Institute for Health Research, United Kingdom
Active, not recruiting
Wed, 15 Jul 2015 12:00:00 EDT

ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients

Condition:   Renal Transplantation
Interventions:   Drug: Everolimus (RAD001);   Drug: Calcineurin Inhibitors (CNI);   Drug: Mycophenolate acid (MPA)/Azathioprine (AZA);   Drug: Steroids
Sponsor:   Novartis Pharmaceuticals
Completed
Thu, 15 Sep 2005 12:00:00 EDT

A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Condition:   Neuromyelitis Optica Spectrum Disorder
Interventions:   Drug: satralizumab;   Drug: azathioprine (AZA);   Drug: mycophenolate mofetil (MMF);   Drug: oral corticosteroids
Sponsor:   Hoffmann-La Roche
Recruiting
Wed, 09 Dec 2020 12:00:00 EST

Clinical Prognosis and Progression of Myasthenia Gravis Patients

Condition:   Myasthenia Gravis
Intervention:   Drug: Symptomatic Treatment, Steroids, Immunosuppressive Agents, Plasma Exchange(PE), Intravenous Immunoglobulin(IVIg)
Sponsor:   Da, Yuwei, M.D.
Recruiting
Tue, 24 Sep 2019 12:00:00 EDT

Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

Condition:   Systemic Lupus Erythematosus (SLE)
Interventions:   Drug: Anifrolumab;   Drug: Standard of Care
Sponsors:   Oklahoma Medical Research Foundation;   NYU Langone Health;   Yale University;   Piedmont Heart Institute, Inc., Atlanta, GA;   Columbia University
Recruiting
Wed, 27 Jan 2021 12:00:00 EST

Conventional Step-Up Versus Infliximab Monotherapy in Patients With Ulcerative Colitis (P05553)

Condition:   Colitis, Ulcerative
Interventions:   Biological: Infliximab;   Drug: Prednisolone;   Drug: 5-aminosalicylic acid;   Drug: Azathioprine
Sponsor:   Merck Sharp & Dohme Corp.
Terminated
Fri, 25 Sep 2009 12:00:00 EDT

Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Condition:   Uveitis
Interventions:   Biological: Adalimumab (ADA);   Drug: Conventional immunosuppression (CON)
Sponsor:   JHSPH Center for Clinical Trials
Recruiting
Mon, 04 Feb 2019 12:00:00 EST

Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Drug: Artesunate;   Drug: Curcumin;   Drug: Placebo A;   Drug: Placebo C
Sponsors:   Sanjay Gandhi Postgraduate Institute of Medical Sciences;   St George's University of London, London, UK
Not yet recruiting
Tue, 19 Jan 2021 12:00:00 EST

Chronotherapy in Inflammatory Bowel Disease

Condition:   Inflammatory Bowel Diseases
Interventions:   Drug: Evening Group;   Drug: Morning Group
Sponsor:   Rush University Medical Center
Recruiting
Thu, 12 Mar 2020 12:00:00 EDT

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

Conditions:   Vasculitis;   Wegener's Granulomatosis;   Microscopic Polyangiitis;   Churg-Strauss Syndrome;   Polyarteritis Nodosa
Interventions:   Drug: prednisone, methylprednisolone,cyclophosphamides;   Drug: Cyclophosphamide, Azathioprine,prednisone,methylprednisolone;   Drug: Mycophenolate mofetil,methotrexate
Sponsor:   Assistance Publique - Hôpitaux de Paris
Completed
Tue, 28 Mar 2006 12:00:00 EST

The Effect of Eltrombopag on the Expression of Platelet Collagen Receptor GPVI in Pediatric ITP.

Condition:   Idiopathic Thrombocytopenic Purpura
Interventions:   Drug: Eltrombopag;   Drug: conventional
Sponsor:   Nayera Hazaa Elsherif
Recruiting
Fri, 26 Jan 2018 12:00:00 EST

The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease

Conditions:   Inflammatory Bowel Disease;   Crohn's Disease
Interventions:   Drug: Infliximab;   Drug: thiopurine
Sponsors:   Ernest Seidman;   University of Toronto;   University of Calgary;   University of Alberta
Unknown status
Mon, 25 May 2015 12:00:00 EDT

Outcome in Patients With Recent Onset Polymyositis and Dermatomyositis

Conditions:   Polymyositis;   Dermatomyositis
Intervention:   Drug: Immunosuppressive Agents
Sponsor:   Karolinska University Hospital
Completed
Tue, 19 Mar 2013 12:00:00 EDT

Preemptive HLA Genotyping for the Safe Use of Infliximab-combination Therapy in Inflammatory Bowel Disease

Conditions:   Inflammatory Bowel Diseases;   Ulcerative Colitis;   Crohn Disease
Interventions:   Genetic: HLADQA1*05A>G screening;   Other: Standard of Care
Sponsor:   Western University, Canada
Not yet recruiting
Mon, 30 Sep 2019 12:00:00 EDT

Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

Conditions:   Kidney Transplantation;   Kidney Transplant Rejection
Interventions:   Drug: Twice-daily Tacrolimus;   Drug: Once-daily envarsus XR;   Drug: Induction Immunosuppression with Basiliximab or Rabbit Anti Thymoglobulin (rATG);   Drug: Methylprednisolone, prednisone;   Drug: Mycophenolate mofetil (MMF) or Mycophenolic acid (MPA);   Drug: Azathioprine
Sponsors:   University of Southern California;   Veloxis Pharmaceuticals
Recruiting
Fri, 26 Feb 2021 12:00:00 EST

Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients

Condition:   End-Stage Renal Disease
Interventions:   Drug: Conversion to Advagraf;   Drug: conversion of non-immunosuppressant drugs to once daily;   Drug: Conversion to once daily MPA
Sponsors:   University of British Columbia;   Astellas Pharma Canada, Inc.
Active, not recruiting
Mon, 27 Apr 2015 12:00:00 EDT

A proSpective Randomized Controlled Trial comParing infliximAb-antimetabolites Combination Therapy to Anti-metabolites monotheRapy and Infliximab monothErapy in Crohn's Disease Patients in Sustained Steroid-free Remission on Combination Therapy

Condition:   Crohn's Disease
Interventions:   Drug: INFLIXIMAB;   Drug: AZATHIOPRINE;   Drug: MERCAPTOPURINE;   Drug: Methotrexate
Sponsors:   Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives;   Saint-Louis Hospital, Paris, France
Active, not recruiting
Fri, 27 Jun 2014 12:00:00 EDT

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis

Conditions:   Vasculitis;   Wegener's Granulomatosis;   Microscopic Polyangiitis
Interventions:   Drug: Rituximab plus cyclophosphamide placebo (rituximab group);   Drug: Cyclophosphamide plus rituximab placebo (control group);   Drug: Azathioprine;   Drug: Methylprednisolone (or other glucocorticoid);   Drug: Prednisone
Sponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   Immune Tolerance Network (ITN);   Genentech, Inc.
Completed
Fri, 25 Feb 2005 12:00:00 EST

A Study of Subcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis
Interventions:   Drug: Azathioprine;   Drug: Chloroquine;   Drug: Hydroxychloroquine;   Drug: Leflunomide;   Drug: Methotrexate;   Drug: Sulfasalazine;   Drug: Tocilizumab
Sponsor:   Hoffmann-La Roche
Completed
Fri, 13 Sep 2013 12:00:00 EDT

Natural History Study of Azathioprine Adherence

Condition:   Kidney Transplant
Intervention:   Other: observation
Sponsor:   Thomas E. Nivens, MD
Completed
Fri, 02 Sep 2005 12:00:00 EDT

Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)

Conditions:   Wegener's Granulomatosis;   Vasculitis
Interventions:   Drug: mycophenolate mofetil;   Drug: cyclophosphamide
Sponsor:   University Medical Center Groningen
Unknown status
Tue, 15 Feb 2005 12:00:00 EST

Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study

Condition:   Choroidal Neovascularization
Intervention:   Drug: bevacizumab
Sponsors:   University of Sao Paulo;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Unknown status
Thu, 19 Dec 2013 12:00:00 EST

Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression

Condition:   Immunosuppression
Intervention:   Biological: Flu Vaccine
Sponsor:   Emory University
Completed
Mon, 26 Nov 2012 12:00:00 EST

Aerosol Cyclosporine for Prevention of Lung Rejection

Condition:   Lung Diseases
Interventions:   Drug: cyclosporine;   Drug: tacrolimus;   Drug: prednisone;   Drug: azathioprine
Sponsor:   National Heart, Lung, and Blood Institute (NHLBI)
Completed
Thu, 22 Dec 2005 12:00:00 EST

Etanercept for the Treatment of Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Drug: Etanercept;   Drug: Lupus Treatment- Standard of Care;   Drug: Placebo
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Terminated
Wed, 14 Mar 2007 12:00:00 EDT

Treatment Outcome of Uveitis in Autoimmune Diseases

Condition:   Autoimmune Uveitis
Intervention:   Drug: Corticosteroid Series
Sponsor:   Assiut University
Unknown status
Fri, 22 Mar 2019 12:00:00 EDT

Granulocyte-monocyte Apheresis in Ulcerative Colitis

Condition:   Ulcerative Colitis
Intervention:   Device: apheresis
Sponsor:   Valduce Hospital
Completed
Fri, 16 Jun 2017 12:00:00 EDT

Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.

Condition:   Crohn's Disease
Interventions:   Dietary Supplement: Whey protein;   Dietary Supplement: Soy protein
Sponsors:   University of Campinas, Brazil;   Fundação de Amparo à Pesquisa do Estado de São Paulo
Completed
Tue, 08 Oct 2013 12:00:00 EDT

Pirfenidone in the Chronic Hypersensitivity Pneumonitis Treatment

Conditions:   Alveolitis Extrinsic Allergic;   Pulmonary Fibrosis
Interventions:   Drug: Placebo;   Drug: Pirfenidone
Sponsor:   Grupo Medifarma, S. A. de C. V.
Unknown status
Tue, 14 Jul 2015 12:00:00 EDT

Methotrexate-associated Anti-TNF Combination Therapy, the Neglected One !

Condition:   Chronic Inflammatory Bowel Disease
Intervention:  
Sponsors:   University Hospital, Montpellier;   Rennes University Hospital - CHU Pontchaillou
Active, not recruiting
Thu, 12 Dec 2019 12:00:00 EST

Combined Immunosuppression for Pediatric Crohn's Disease

Conditions:   Crohn Disease;   Infliximab;   Immunosuppression;   Children, Only
Interventions:   Drug: Infliximab and immunosuppressives;   Drug: Infliximab
Sponsor:   Children's Hospital of Fudan University
Not yet recruiting
Tue, 14 Sep 2021 12:00:00 EDT

The Effect of Infliximab on Sperm Quality

Conditions:   Crohn's Disease;   Ulcerative Colitis
Intervention:   Other: sperm quality test
Sponsor:   Tel-Aviv Sourasky Medical Center
Unknown status
Wed, 03 Sep 2008 12:00:00 EDT

A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)

Conditions:   Lupus Nephritis;   Systemic Lupus Erythematosus
Interventions:   Drug: Corticosteroids;   Drug: Cyclophosphamide;   Drug: Mycophenolate Mofetil;   Drug: Ocrelizumab;   Drug: Placebo;   Drug: Azathioprine
Sponsors:   Genentech, Inc.;   Roche Pharma AG
Terminated
Fri, 29 Feb 2008 12:00:00 EST

An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen

Conditions:   Crohn's Disease;   Ulcerative Colitis
Intervention:  
Sponsor:   Medicpen AB
Completed
Wed, 10 Jun 2009 12:00:00 EDT

Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis

Conditions:   SLE;   Lupus Nephritis;   Renal Insufficiency;   End-stage Renal Disease
Interventions:   Drug: Tacrolimus;   Drug: cyclophosphamide
Sponsor:   Zhejiang University
Completed
Wed, 22 Sep 2010 12:00:00 EDT

Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis

Condition:   Ulcerative Colitis
Interventions:   Drug: ABX464 25mg;   Drug: ABX464 50mg;   Drug: ABX464 100mg;   Drug: Placebo
Sponsor:   Abivax S.A.
Completed
Fri, 30 Nov 2018 12:00:00 EST

Multicenter Registry of Pediatric Lupus Nephritis in China

Conditions:   Lupus Nephritis;   Children;   Steroid;   Immunosuppressive Treatment
Interventions:   Drug: Corticosteroid;   Drug: Hydroxychloroquine;   Drug: Cyclophosphamide;   Drug: Mycophenolate Mofetil;   Drug: Azathioprine;   Drug: Tacrolimus;   Drug: Cyclosporine A;   Drug: Rituximab
Sponsors:   Xiqiang Dang;   The Children's Hospital Affiliated to Suzhou University;   Shandong Provincial Hospital;   Guizhou Provincial People's Hospital;   LanZhou University;   The First Affiliated Hospital of Inner Mongolia Medical College;   People's Hospital of Zhangjiajie;   Puyang Oilfield General Hospital;   The First Affiliated Hospital of Anhui Medical University;   Guizhou Maternal and Child Health Care Hospital;   The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University;   Shenzhen Children's Hospital;   The Second Affiliated Hospital of Harbin Medical University;   Yichang Central People's Hospital;   Xian Children's Hospital;   Wuhan Children's Hospital, Tongji Medical College, Huazhong University of Science & Technology;   The First People's Hospital of Yunnan;   The First Affiliated Hospital of Xiamen University;   The First Affiliated Hospital of Xinxiang Medical College;   Shanxi Provincial Maternity and Children's Hospital;   Liaocheng People's Hospital;   Fujian Provincial Hospital;   First Affiliated Hospital of Guangxi Medical University;   Second Hospital of Lanzhou University;   Guangzhou First People's Hospital;   The Second Hospital of Shandong University;   Children's Hospital of Hebei Province;   Beijing Children's Hospital;   Zhengzhou Children's Hospital;   The Children's Hospital of Chongqing Medical University;   Wuxi Children's Hospital;   The Children's Hospital of Fudan University;   Shanghai Children's Medical Center;   Qilu Children's Hospital of Shandong University
Recruiting
Thu, 03 Jan 2019 12:00:00 EST

RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency

Condition:   Liver Transplantation
Interventions:   Drug: Everolimus;   Drug: Calcineurin inhibitors (CNI);   Drug: Mycophenolate acid (MPA)/ Azathioprine (AZA);   Drug: Steroids
Sponsor:   Novartis Pharmaceuticals
Completed
Tue, 20 Dec 2005 12:00:00 EST

Acthar Gel for Chronic Pulmonary Sarcoidosis (ACPS)

Conditions:   Sarcoidosis;   Pulmonary Sarcoidosis
Intervention:   Drug: Acthar gel
Sponsors:   University of Cincinnati;   Mallinckrodt
Unknown status
Fri, 11 Jul 2014 12:00:00 EDT

Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

Conditions:   Kidney Transplantation;   Skin Cancer
Interventions:   Drug: Sirolimus;   Drug: Azathioprine;   Drug: Mycophenolate;   Drug: Ciclosporin;   Drug: Tacrolimus
Sponsor:   Charite University, Berlin, Germany
Terminated
Fri, 20 Mar 2009 12:00:00 EDT

Effect of Electronic Cigarettes on Platelets, Endothelium and Inflammation

Condition:   Smoking
Intervention:   Device: E-cigarette/tobacco Smoking Exposure
Sponsor:   NYU Langone Health
Withdrawn
Mon, 25 Jan 2016 12:00:00 EST

Comparison of Mycophenolate Mofetil and Cyclophosphamide for Active Takayasu's Arteritis

Condition:   Takayasu Arteritis
Interventions:   Drug: MMF;   Drug: CYC;   Drug: Glucocorticoids;   Drug: MTX;   Drug: AZA
Sponsors:   Chinese SLE Treatment And Research Group;   Peking Union Medical College Hospital
Unknown status
Thu, 30 Mar 2017 12:00:00 EDT

Systemic Therapies for Pediatric Atopic Dermatitis

Condition:   Dermatitis, Atopic
Intervention:  
Sponsors:   Rady Children's Hospital, San Diego;   University of California, San Diego
Unknown status
Thu, 06 Oct 2011 12:00:00 EDT

Pneumococcal Vaccination of Crohn Patients

Condition:   Crohns Disease
Interventions:   Biological: Prevenar 13;   Biological: Pneumovax
Sponsors:   Statens Serum Institut;   Hvidovre University Hospital;   Herlev Hospital
Completed
Fri, 20 Sep 2013 12:00:00 EDT

Anti-Cytokine Therapy for Vasculitis

Conditions:   Wegener's Granulomatosis;   Renal Limited Vasculitis;   Microscopic Polyangiitis
Interventions:   Biological: Infliximab;   Drug: Cyclophosphamide;   Drug: Prednisolone;   Drug: Azathioprine;   Procedure: Plasma exchange;   Drug: Mycophenolate mofetil;   Drug: Methylprednisolone
Sponsor:   University Hospital Birmingham NHS Foundation Trust
Completed
Tue, 16 Sep 2008 12:00:00 EDT

Impact of Anti-Tumor Necrosis Factor (TNF) Antibodies on the T-lymphocyte and Macrophage Cooperation in Crohn Disease

Condition:   Crohn Disease
Intervention:   Procedure: rectosigmoïdal biopsies
Sponsor:   Centre Hospitalier Universitaire de Nice
Terminated
Wed, 21 Nov 2007 12:00:00 EST

Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients

Conditions:   COVID-19;   Immunosuppression;   Vaccine Response Impaired
Intervention:   Drug: Reduction in antimetabolite immunosuppression
Sponsors:   University of California, Davis;   CareDx
Recruiting
Wed, 29 Sep 2021 12:00:00 EDT

A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)

Condition:   Systemic Lupus Erythematosus
Interventions:   Drug: Prednisone;   Drug: Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate);   Drug: Methylprednisolone;   Drug: Ocrelizumab;   Drug: Placebo
Sponsors:   Genentech, Inc.;   Roche Pharma AG
Terminated
Fri, 05 Oct 2007 12:00:00 EDT

Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

Condition:   Systemic Lupus Erythematosus
Interventions:   Biological: Placebo plus standard therapy;   Biological: RC18 160 mg plus standard therapy
Sponsor:   RemeGen Co., Ltd.
Active, not recruiting
Mon, 09 Sep 2019 12:00:00 EDT

Brentuximab Vedotin in Early Diffuse Cutaneous Systemic Sclerosis

Condition:   Diffuse Cutaneous Systemic Sclerosis
Intervention:   Drug: Brentuximab Vedotin
Sponsors:   Lawson Health Research Institute;   Seagen Inc.
Recruiting
Mon, 26 Jun 2017 12:00:00 EDT

Baricitinib in Patients With Relapsing or naïve Dermatomyositis

Condition:   Dermatomyositis
Interventions:   Drug: Baricitinib;   Drug: Placebo
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Thu, 22 Jul 2021 12:00:00 EDT

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease

Condition:   Sickle Cell Disease
Intervention:   Drug: CD34 selected T-cell depleted allogeneic SCT
Sponsors:   New York Medical College;   UCSF Benioff Children's Hospital Oakland;   Medical College of Wisconsin;   Washington University School of Medicine;   Tufts Medical Center;   University of California, San Francisco;   University of California, Los Angeles;   Miltenyi Biomedicine GmbH;   Ann & Robert H Lurie Children's Hospital of Chicago
Active, not recruiting
Fri, 28 Oct 2011 12:00:00 EDT

Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

Condition:   Moderate to Severe Ulcerative Colitis
Intervention:  
Sponsor:   AbbVie
Terminated
Thu, 20 Mar 2014 12:00:00 EDT

Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function

Condition:   Chronic Allograft Nephropathy
Intervention:   Drug: Cyclosporine
Sponsors:   University Hospital Birmingham;   Novartis
Unknown status
Wed, 10 Oct 2007 12:00:00 EDT

Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome

Condition:   Churg-Strauss Syndrome
Intervention:   Biological: HPC cell infusion
Sponsor:   Mounzer Agha
Terminated
Tue, 05 Apr 2016 12:00:00 EDT

Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis
Interventions:   Drug: SARILUMAB;   Drug: Azathioprine;   Drug: Chloroquine;   Drug: Hydroxychloroquine;   Drug: Leflunomide;   Drug: Methotrexate;   Drug: Sulfasalazine
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Completed
Wed, 28 Feb 2018 12:00:00 EST

Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection

Condition:   Kidney Transplant Failure and Rejection
Intervention:   Drug: Everolimus
Sponsor:   Hospices Civils de Lyon
Recruiting
Mon, 20 May 2019 12:00:00 EDT

Biomarkers to Predict the Success of Immunosuppression Withdrawal in Autoimmune Hepatitis

Condition:   Autoimmune Hepatitis
Intervention:   Behavioral: Immunosuppression withdrawal
Sponsor:   Hospital Clinic of Barcelona
Recruiting
Thu, 18 Oct 2018 12:00:00 EDT

Predicting Response to Standardized Pediatric Colitis Therapy

Condition:   Ulcerative Colitis
Interventions:   Drug: Mesalazine;   Drug: IV Corticosteroid;   Drug: Oral Corticosteroids;   Other: Additional Therapies;   Procedure: Colectomy
Sponsors:   Connecticut Children's Medical Center;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed
Wed, 22 Feb 2012 12:00:00 EST

Uterine Transplant in Absolute Uterine Infertility (AUIF)

Condition:   Female Infertility
Intervention:   Procedure: Uterine Transplant
Sponsor:   Brigham and Women's Hospital
Not yet recruiting
Mon, 18 Apr 2016 12:00:00 EDT

Once Daily Immunosuppression Regimen

Condition:   Kidney Transplant; Complications
Interventions:   Drug: Once daily immunosuppression regimen;   Drug: Twice daily immunosuppression regimen
Sponsors:   Washington University School of Medicine;   Veloxis Pharmaceuticals
Recruiting
Wed, 13 Jun 2018 12:00:00 EDT

Abatacept in Patients With Birdshot HLA A29 Uveitis

Conditions:   Eye Diseases;   Uveitis
Intervention:   Drug: Abatacept 125 MG/ML Prefilled Syringe
Sponsors:   Universitaire Ziekenhuizen Leuven;   Ziekenhuis Netwerk Antwerpen (ZNA)
Active, not recruiting
Tue, 12 Mar 2019 12:00:00 EDT

Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment

Condition:   Graft Versus Host Disease
Intervention:   Drug: sirolimus
Sponsors:   Fred Hutchinson Cancer Research Center;   National Cancer Institute (NCI)
Completed
Wed, 10 Mar 2004 12:00:00 EST

Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis

Conditions:   Systemic Sclerosis;   Interstitial Lung Diseases
Intervention:  
Sponsors:   Gabriela Riemekasten;   European Union;   University of Giessen;   University of Zurich;   University of Paris 5 - Rene Descartes;   University of Florence;   University of Campania "Luigi Vanvitelli";   University of Basel;   University College, London;   Charite University, Berlin, Germany;   University of Pecs;   University of Leeds;   Schoen Klinik Hamburg Eilbek
Unknown status
Tue, 21 May 2013 12:00:00 EDT

Efficacy and Safety of Oral E5501 Plus Standard of Care for the Treatment of Thrombocytopenia in Adults With Chronic Immune Thrombocytopenia (Amendment 02)

Conditions:   Chronic Thrombocytopenia;   Immune Thrombocytopenia
Interventions:   Drug: Avatrombopag;   Drug: Placebo;   Drug: Standard of care
Sponsor:   Eisai Inc.
Completed
Thu, 22 Sep 2011 12:00:00 EDT

A Phase 3, Multicenter, Randomized, Double-blind,Active-controlled, Parallel-group Trial With an Open-labelExtension Phase to Evaluate the Efficacy and Safety of OralE5501 Versus Eltrombopag, in Adults With Chronic ImmuneThrombocytopenia (Idiopathic Thrombocytopenic Purpura)

Condition:   Idiopathic Thrombocytopenic Purpura
Interventions:   Drug: Eltrombopag;   Drug: Avatrombopag;   Drug: Standard of care
Sponsor:   Eisai Inc.
Terminated
Wed, 14 Sep 2011 12:00:00 EDT

Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap Syndrome

Conditions:   Hepatitis, Autoimmune;   Cholangitis;   Liver Cirrhosis, Biliary;   Cholestasis
Interventions:   Drug: Ursodeoxycholic acid combination of immunosuppressive agents;   Drug: Ursodeoxycholic Acid
Sponsor:   Xiaoli Fan
Recruiting
Tue, 18 Oct 2016 12:00:00 EDT

Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus

Condition:   Systemic Lupus Erythematosus
Intervention:   Drug: rituximab
Sponsor:   Chinese University of Hong Kong
Completed
Fri, 09 Nov 2007 12:00:00 EST

Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)

Condition:   Systemic Lupus Erythematosus
Interventions:   Procedure: Leukapheresis;   Procedure: Non-myeloablative high dose immunosuppressive therapy conditioning (HDIT);   Procedure: Autologous CD34+HPC transplantation (HSCT);   Procedure: Plasmapheresis;   Drug: Rabbit anti-thymocyte globulin;   Drug: Methylprednisolone;   Drug: Growth colony stimulating factor (G-CSF);   Drug: Corticosteroids;   Drug: Mycophenolate mofetil;   Drug: Azathioprine;   Drug: Intravenous immunoglobulin;   Drug: Methotrexate;   Drug: Rituximab;   Drug: Leflunomide
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Withdrawn
Fri, 30 Sep 2005 12:00:00 EDT

Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease

Conditions:   COVID;   Kidney Transplant; Complications;   Immunosuppression
Intervention:   Other: Maintenance or reduction of immunosuppression
Sponsor:   Brigham and Women's Hospital
Withdrawn
Tue, 09 Jun 2020 12:00:00 EDT

To Evaluate 1 Year Extension Study of the Efficacy and Safety of Tocilizumab in Patients With Moderate to Severe Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis
Interventions:   Drug: Tocilizumab;   Drug: DMARDs
Sponsor:   JW Pharmaceutical
Completed
Thu, 09 Dec 2010 12:00:00 EST

Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

Condition:   Rheumatoid Arthritis
Interventions:   Drug: etanercept;   Drug: non-biologic anti-rheumatic drugs
Sponsor:   Pfizer
Completed
Fri, 20 Jul 2012 12:00:00 EDT

The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Drug: MMF-MMF;   Drug: CTX-AZA
Sponsor:   The University of Hong Kong
Unknown status
Fri, 04 Nov 2016 12:00:00 EDT

Optimal MTX Dose With Folic Acid Randomized Case-control Trial

Condition:   Rheumatoid Arthritis
Interventions:   Drug: MTX;   Drug: Folic Acid;   Drug: DMARDs
Sponsors:   Sun Yat-sen University;   Shanghai Pharmaceuticals Holding Co., Ltd
Unknown status
Mon, 26 Aug 2019 12:00:00 EDT

Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

Condition:   Renal Transplant Patients at High-risk for Skin Cancer
Intervention:   Drug: Sirolimus
Sponsor:   University Hospital of Berlin
Terminated
Fri, 22 Feb 2013 12:00:00 EST

Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

Condition:   Hepatocellular Carcinoma
Interventions:   Drug: CNI, MMF, Steroids, Aza etc. (mTOR inhibitor free);   Drug: Sirolimus
Sponsor:   University of Regensburg
Completed
Tue, 25 Jul 2006 12:00:00 EDT

Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease

Condition:   Behcet's Syndrome
Interventions:   Drug: Rituximab;   Drug: Cytotoxic Combination
Sponsors:   Tehran University of Medical Sciences;   Hoffmann-La Roche
Completed
Wed, 23 Apr 2008 12:00:00 EDT

Causes of Visual Loss in Retinal Disease

Conditions:   Uveitis;   Scleritis
Intervention:   Drug: Immunosuppressive Agents
Sponsor:   Royal Surrey County Hospital NHS Foundation Trust
Unknown status
Thu, 07 Jun 2012 12:00:00 EDT

Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

Condition:   Systemic Lupus Erythematosus
Interventions:   Drug: Belimumab 1 mg/kg;   Drug: Belimumab 10 mg/kg;   Drug: Placebo
Sponsors:   GlaxoSmithKline;   Human Genome Sciences Inc.
Completed
Fri, 02 Aug 2013 12:00:00 EDT

Prevalence of Cytomegalovirus Infection in Patients With Quiescent Ulcerative Colitis

Conditions:   Ulcerative Colitis;   Cytomegalovirus Infections
Intervention:  
Sponsor:   University of British Columbia
Unknown status
Thu, 18 Feb 2016 12:00:00 EST

Multicenter Uveitis Steroid Treatment (MUST) Trial

Condition:   Uveitis
Interventions:   Drug: fluocinolone acetonide intraocular implant;   Drug: oral corticosteroid with immunosuppressive agents as needed
Sponsors:   JHSPH Center for Clinical Trials;   National Eye Institute (NEI)
Completed
Mon, 22 Aug 2005 12:00:00 EDT

Different Immunosuppressive Treatment in iMN

Condition:   Idiopathic Membranous Nephropathy
Interventions:   Drug: Prednisone;   Drug: Cyclophosphamide;   Drug: Rituximab
Sponsor:   Peking Union Medical College Hospital
Recruiting
Tue, 09 Feb 2021 12:00:00 EST

Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound

Condition:   Sickle Cell Disease
Interventions:   Procedure: Hematopoietic Stem Cell Transplantation;   Device: CliniMACS;   Drug: See intervention description
Sponsor:   St. Jude Children's Research Hospital
Completed
Fri, 09 Sep 2005 12:00:00 EDT

A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

Condition:   Adverse Drug Reaction
Intervention:   Other: Pharmacogenetic Intervention Arm (pharmacogenetic testing)
Sponsors:   Indiana University;   National Human Genome Research Institute (NHGRI)
Completed
Fri, 21 Nov 2014 12:00:00 EST

Effect of Immunosuppression in IgA Nephropathy

Condition:   Biopsy-proven IgA Nephropathy
Interventions:   Drug: Immunosuppressive treatment;   Other: intensive supportive care
Sponsor:   Yonsei University
Not yet recruiting
Mon, 19 Mar 2018 12:00:00 EDT

Supportive Versus Immunosuppressive Therapy for the Treatment Of Progressive IgA Nephropathy

Condition:   IgA Nephropathy
Interventions:   Drug: supportive therapy with: ACE-inhibitor / ARB / Statin;   Drug: supportive and immunosuppressive therapy
Sponsor:   RWTH Aachen University
Completed
Wed, 07 Nov 2007 12:00:00 EST

Mycophenolate Mofetil for Reducing Cardiovascular Risk in Renal Transplant Recipients

Conditions:   Kidney Transplantation;   Cardiovascular Diseases
Interventions:   Drug: mycophenolate mofetil;   Other: standard immunosuppression
Sponsors:   Ramesh Prasad;   Hoffmann-La Roche
Terminated
Mon, 04 Oct 2010 12:00:00 EDT

The Clinical Efficacy of DFPP in Patients With AAGN

Condition:   Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions:   Other: DFPP&CTX;   Drug: CTX
Sponsor:   Zhi-Hong Liu, M.D.
Terminated
Wed, 19 Nov 2014 12:00:00 EST

Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab

Condition:   Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions:   Drug: Standard of care treatment;   Drug: eculizumab
Sponsors:   University of North Carolina, Chapel Hill;   Alexion Pharmaceuticals;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Withdrawn
Wed, 12 Jan 2011 12:00:00 EST

Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

Condition:   Systemic Lupus Erythematosus
Interventions:   Biological: Placebo plus standard therapy;   Biological: RC18 80 mg plus standard therapy;   Biological: RC18 160 mg plus standard therapy;   Biological: RC18 240 mg plus standard therapy
Sponsor:   RemeGen Co., Ltd.
Completed
Wed, 31 Aug 2016 12:00:00 EDT

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis

Conditions:   Granulomatosis With Polyangiitis;   Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis
Interventions:   Drug: Rituximab;   Drug: Tocilizumab;   Drug: Abatacept
Sponsors:   Assistance Publique - Hôpitaux de Paris;   URC-CIC Paris Descartes Necker Cochin
Not yet recruiting
Tue, 04 May 2021 12:00:00 EDT

Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls

Conditions:   Anal Squamous Intraepithelial Lesion (ASIL);   HPV DNA
Intervention:   Procedure: Anal Pap smear and HPV DNA testing
Sponsor:   Stanford University
Completed
Thu, 23 May 2013 12:00:00 EDT

Sustained Humoral and Cell-Mediated Immunogenicity of COVID-19 Vaccines in Patients With Inflammatory Bowel Disease

Condition:   Inflammatory Bowel Diseases
Intervention:   Biological: COVID-19 Vaccine
Sponsors:   GI Alliance;   Janssen, LP;   University of Wisconsin, Madison;   Mayo Clinic
Not yet recruiting
Fri, 20 Aug 2021 12:00:00 EDT

Immunogenicity of Influenza, Pneumococcal and Hepatitis B Vaccines in IBD Patients Treated With Vedolizumab

Condition:   Inflammatory Bowel Diseases
Interventions:   Biological: Pneumococcal Pneumonia vaccine;   Biological: Influenza vaccine;   Biological: Hepatitis B vaccine
Sponsor:   Boston Medical Center
Completed
Fri, 17 Feb 2017 12:00:00 EST

Withdraw Drug in Stable IgG4-Related Disease

Condition:   Autoimmune Diseases
Intervention:   Drug: Drug free, IS monotherapy and GC combined with IS
Sponsors:   Peking Union Medical College Hospital;   Chinese PLA General Hospital;   Peking University People's Hospital;   The People's Hospital of Hebei Province;   Shengjing Hospital;   Tongji Hospital
Not yet recruiting
Fri, 11 Oct 2019 12:00:00 EDT

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

Conditions:   Neuromyelitis Optica (NMO);   NMO Spectrum Disorder (NMOSD)
Interventions:   Drug: Satralizumab;   Drug: Placebo;   Drug: Baseline Treatment
Sponsors:   Hoffmann-La Roche;   Chugai Pharmaceutical
Active, not recruiting
Tue, 07 Jan 2014 12:00:00 EST

A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis
Interventions:   Drug: Tocilizumab;   Drug: Placebo;   Drug: Permitted DMARDs
Sponsor:   Hoffmann-La Roche
Completed
Wed, 19 Sep 2007 12:00:00 EDT

Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary Fibrosis

Condition:   Idiopathic Pulmonary Fibrosis
Interventions:   Biological: Autologous Stromal Vascular Fraction (SVF);   Biological: Autologous Adipose Derived MSCs (ADMSCs);   Other: Control
Sponsor:   Kasiak Research Pvt. Ltd.
Unknown status
Fri, 09 May 2014 12:00:00 EDT

Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis

Condition:   Lupus Nephritis
Interventions:   Biological: Placebo plus standard therapy;   Biological: Belimumab 10 mg/kg plus standard therapy;   Drug: Standard therapy
Sponsors:   Human Genome Sciences Inc., a GSK Company;   GlaxoSmithKline
Completed
Thu, 12 Jul 2012 12:00:00 EDT

Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)

Condition:   Systemic Lupus Erythematosus
Interventions:   Other: Group B SLE one blood donation;   Other: Blood drawing only Group C;   Drug: Group A SLE prospective study
Sponsors:   Oklahoma Medical Research Foundation;   Pfizer
Completed
Thu, 01 Oct 2009 12:00:00 EDT

Rituximab in Eosinophilic Granulomatosis With Polyangiitis

Condition:   Eosinophilic Granulomatosis With Polyangiitis (EGPA)
Interventions:   Drug: Rituximab;   Drug: Placebo-rituximab;   Drug: Cyclophosphamide;   Drug: Placebo-cyclophosphamide
Sponsors:   Assistance Publique - Hôpitaux de Paris;   French Vasculitis Study Group
Completed
Tue, 21 Jun 2016 12:00:00 EDT

Cross Sectional Study of Vaccine Antibody Response in Inflammatory Bowel Disease Patients

Condition:   Inflammatory Bowel Disease (IBD)
Intervention:   Procedure: Blood Draw/Data Collection
Sponsor:   University of Wisconsin, Madison
Completed
Tue, 05 May 2015 12:00:00 EDT

Efficacy Study of Pneumococcal Vaccination in Crohn's Disease

Condition:   Crohn's Disease
Intervention:   Drug: 23-valent polysaccharide pneumococcal vaccine
Sponsors:   Kyunghee University Medical Center;   Wonju Severance Christian Hospital;   Seoul National University Hospital;   Asan Medical Center;   Soonchunhyang University Hospital;   Ewha Womans University;   Kosin University Gospel Hospital;   Chung-Ang University Hosptial, Chung-Ang University College of Medicine;   Inje University;   The Catholic University of Korea;   Keimyung University Dongsan Medical Center;   Korea University;   Wonkwang University;   Severance Hospital;   Konkuk University Hospital
Completed
Mon, 09 Jan 2012 12:00:00 EST

Efficacy and Safety of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis

Condition:   Rheumatoid Arthritis
Interventions:   Drug: tocilizumab;   Drug: DMARDs;   Drug: Placebo
Sponsor:   JW Pharmaceutical
Completed
Thu, 30 Sep 2010 12:00:00 EDT

Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib

Condition:   Inflammatory Bowel Diseases
Intervention:   Biological: SHINGRIX
Sponsor:   Boston Medical Center
Recruiting
Thu, 19 Jul 2018 12:00:00 EDT

An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies

Condition:   Rheumatoid Arthritis
Interventions:   Drug: Tocilizumab;   Drug: Disease-modifying anti-rheumatic drugs;   Drug: Non-steroidal anti-inflammatory drugs;   Drug: Oral corticosteroids
Sponsor:   Hoffmann-La Roche
Completed
Wed, 23 Jul 2008 12:00:00 EDT

Seroprevalence of Anti-bodies Against Clostridium Difficile Toxins and Prevalence of Asymptomatic Carriage of Clostridium Difficile in IBD Patients.

Conditions:   Clostridium Difficile;   Inflammatory Bowel Diseases
Intervention:   Diagnostic Test: Determination of serum anti-toxin Abs for C. difficile
Sponsor:   Hospital Universitari de Bellvitge
Recruiting
Tue, 26 Mar 2019 12:00:00 EDT

Investigating Significant Health Trends in Idiopathic Pulmonary Fibrosis

Condition:   Idiopathic Pulmonary Fibrosis
Intervention:  
Sponsors:   Technische Universität Dresden;   GWT-TUD GmbH;   Boehringer Ingelheim
Recruiting
Fri, 28 Sep 2012 12:00:00 EDT

A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus

Condition:   Lupus Erythematosus, Systemic
Interventions:   Drug: Ustekinumab IV;   Drug: Placebo Infusion;   Drug: Placebo SC;   Drug: Ustekinumab SC;   Other: Concomitant Medication
Sponsor:   Janssen Research & Development, LLC
Completed
Wed, 28 Jan 2015 12:00:00 EST

Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Conditions:   Acute Lymphoblastic Leukemia;   B Acute Lymphoblastic Leukemia;   Mixed Phenotype Acute Leukemia;   T Acute Lymphoblastic Leukemia
Interventions:   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Daunorubicin Hydrochloride;   Drug: Dexamethasone;   Drug: Dexrazoxane Hydrochloride;   Drug: Doxorubicin;   Drug: Etoposide;   Biological: Filgrastim;   Drug: Ifosfamide;   Drug: Imatinib Mesylate;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Methylprednisolone;   Drug: Pegaspargase;   Drug: Prednisolone;   Other: Questionnaire Administration;   Drug: Therapeutic Hydrocortisone;   Drug: Thioguanine;   Drug: Vincristine Sulfate
Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI);   EsPhALL network I-BFM Study Group
Recruiting
Mon, 02 Jan 2017 12:00:00 EST

Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster

Conditions:   Herpes Zoster;   Inflammatory Bowel Diseases;   Crohn Disease;   Ulcerative Colitis
Intervention:  
Sponsor:   University of Wisconsin, Madison
Completed
Tue, 12 Jun 2018 12:00:00 EDT

Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis

Conditions:   Systemic Sclerosis;   Arthritis
Intervention:  
Sponsors:   Prof. Laszlo Czirjak;   European Union;   University of Giessen;   University of Zurich;   University of Paris 5 - Rene Descartes;   University of Florence;   University of Campania "Luigi Vanvitelli";   University of Basel;   University College, London;   Charite University, Berlin, Germany;   University of Leeds;   Schoen Klinik Hamburg Eilbek
Unknown status
Wed, 17 Apr 2013 12:00:00 EDT